stem-cells

Documents about stem-cells

• Video 4_Neuromuscular junction formation by compartmentalized culture using human iPS cell-derived motor neurons and skeletal muscle cells.avi#970832Figshare
• Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)#991790ClinicalTrials.gov
• Retraction Note: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia#1053109Europe PMC
• Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults#685144HAL (France)
• Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma#857664ClinicalTrials.gov
• UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia#877244ClinicalTrials.gov
• Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD#887446ClinicalTrials.gov
• Data Sheet 1_Neuromuscular junction formation by compartmentalized culture using human iPS cell-derived motor neurons and skeletal muscle cells.pdf#970826Figshare
• Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation#801495ClinicalTrials.gov
• Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD#902560ClinicalTrials.gov
• The exposure of primary cultures of human biliary tree stem/progenitor cells (hBTSCs) to different micro-environmental factors induces proliferation, epithelial-mesenchymal transition (EMT) and senescence, which are typical pathological features of human cholangiopathies#340191IRIS
• Additional file 2 of Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer#478450Figshare
• Additional file 1 of Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer#478451Figshare
• Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation#800296ClinicalTrials.gov
• The Improvement of Limbal Epithelial Culture Technique by Using Collagenase to Isolate Limbal Stem Cells#859240ClinicalTrials.gov
• Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.#893967ClinicalTrials.gov
• Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma#141101ClinicalTrials.gov
• Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R#402048DataCite
• Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence#859935ClinicalTrials.gov
• Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System#1046912ClinicalTrials.gov
• A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs#805368ClinicalTrials.gov
• The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN#1009920ClinicalTrials.gov
• Développement d'un modèle in vitro humain de rétinopathie pigmentaire inductible, pour la recherche de molécules à potentiel thérapeutique et la compréhension de mécanismes pathologiques#374585HAL (France)
• Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).#885339ClinicalTrials.gov
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies#858972ClinicalTrials.gov
• Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure#1044370ClinicalTrials.gov
• Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency#1044377ClinicalTrials.gov
• Transcriptomic analysis reveals that BMP4 sensitizes glioblastoma tumor-initiating cells to mechanical cues#620125eScholarship
• Bone regeneration based on stem cells derived from bone marrow, iliac crest, or adipose tissue: a scoping review protocol of clinical applications for dental implant site preparation#1055154Repositorio Universidad del Desarrollo
• Bone marrow-derived cells repopulate the human peritoneal cavity after allogeneic stem cell transplantation / Lamia S. Albesais, Michael Rooney, Stefanie Quickert, Benjamin Giszas, Juliane Sanft, Gita Mall, Arndt Steube, Philipp Reuken, Peter Huppke, Tino Schenk, Andreas Stallmach, Tony Bruns, Sven Stengel#780346Deutsche Nationalbibliothek
• A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System#829496ClinicalTrials.gov
• Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects#1031661ClinicalTrials.gov
• An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis#892645ClinicalTrials.gov
• Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)#906478ClinicalTrials.gov
• Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs#801363ClinicalTrials.gov
• HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies#911752ClinicalTrials.gov
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease#873866ClinicalTrials.gov
• Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant#407722ClinicalTrials.gov
• {'@classid': 'main title', '@classname': 'main title', '@schemeid': 'dnet:dataCite_title', '@schemename': 'dnet:dataCite_title', '@inferred': False, '@provenanceaction': 'sysimport:crosswalk:repository', '@trust': '0.9', '$': 'Epigenetic Manipulation Facilitates the Generation of Skeletal Muscle Cells from Pluripotent Stem Cells'}#491239OpenAIRE
• Bone Marrow Adipose Tissue in Relation to Bone and Energy Metabolism in Obesity and Type 2 Diabetes Mellitus#858482ClinicalTrials.gov
• CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma#230391ClinicalTrials.gov
• A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)#879165ClinicalTrials.gov
• Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma#181754ClinicalTrials.gov
• A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies#851619ClinicalTrials.gov
• Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies#886273ClinicalTrials.gov
• Integrated multi-omics analysis uncovers molecular dysregulation in glucosylceramide synthase-deficient human induced pluripotent stem cells / Julia Beimdiek, Karsten Cirksena, Charlotte Rossdam, Smilla Brand-Merseburger, Astrid Oberbeck, Philippe V. Barbosa, Ana Tzvetkova, Malte Juchem, Christian Bär, Thomas Thum, Axel Schambach, Andreas Pich, Britta Brügger, Andreas W. Kuss, Falk F. R. Büttner#783947Deutsche Nationalbibliothek
• Systemic Biochemical Signature and Functional Quality Index of Calcaneal Bone Marrow Aspirate in Adults Undergoing Foot or Ankle Surgery#993272ClinicalTrials.gov
• A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors#866620ClinicalTrials.gov
• Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)#806979ClinicalTrials.gov
• A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).#1030773ClinicalTrials.gov